Australian Clinical Labs
ACL.AX
#7223
Rank
ยฃ0.29 B
Marketcap
ยฃ1.46
Share price
0.00%
Change (1 day)
4.89%
Change (1 year)

P/S ratio for Australian Clinical Labs (ACL.AX)

P/S ratio at the end of 2024: 0.7297

According to Australian Clinical Labs's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.16. At the end of 2024 the company had a P/S ratio of 0.7297.

P/S ratio history for Australian Clinical Labs from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20240.7297-27.27%
20231.007.66%
20220.9318-13.13%
20211.07